Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.

Anupam Kumar SinghAnuraag JenaPraveen Kumar-MNavneet Sharma Shaji Sebastian

Published in: United European gastroenterology journal (2021)

SARS-CoV-2 infection risk in patients with inflammatory bowel disease is comparable to the general population. Outcomes of COVID-19-positive inflammatory bowel disease patients are worse in ulcerative colitis, those on steroids or 5-aminosalicylates but outcomes are better with biological agents.

Keyphrases

patients with inflammatory bowel disease
coronavirus disease
ulcerative colitis
end stage renal disease
sars cov
respiratory syndrome coronavirus
chronic kidney disease
newly diagnosed
prognostic factors
adipose tissue
skeletal muscle
metabolic syndrome
patient reported outcomes
patient reported